Selected research
Industry Growth & Trends
Global Non-lethal Biochemical Weapons Industry Growth and Trends Forecast to 2032
Market perspective
The global Non-lethal Biochemical Weapons market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Non-lethal Biochemical Weapons include Lamperd Less Lethal, BAE Systems, Inc., QinetiqGroup, Inc., General Dynamics Corporation, TASER International,Inc., Moog, Inc., Raytheon Company, Chemring Group PLC. and Textron Systems, Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Non-lethal Biochemical Weapons market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Non-lethal Biochemical Weapons market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-lethal Biochemical Weapons market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-lethal Biochemical Weapons.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Non-lethal Biochemical Weapons market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Non-lethal Biochemical Weapons Market by Company
Lamperd Less Lethal
BAE Systems, Inc.
QinetiqGroup, Inc.
General Dynamics Corporation
TASER International,Inc.
Moog, Inc.
Raytheon Company
Chemring Group PLC.
Textron Systems, Corp
LRAD Corporation
Non-lethal Biochemical Weapons Segment by Type
Directed Energy
Direct Contact
Non-lethal Biochemical Weapons Segment by Application
Military Forces
Law Enforcement Agencies
Non-lethal Biochemical Weapons Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-lethal Biochemical Weapons market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-lethal Biochemical Weapons and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-lethal Biochemical Weapons.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-lethal Biochemical Weapons manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Non-lethal Biochemical Weapons in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Directed Energy
- Direct Contact
Applications
- Military Forces
- Law Enforcement Agencies
Companies covered
- Lamperd Less Lethal
- BAE Systems, Inc.
- QinetiqGroup, Inc.
- General Dynamics Corporation
- TASER International,Inc.
- Moog, Inc.
- Raytheon Company
- Chemring Group PLC.
- Textron Systems, Corp
- LRAD Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Non-lethal Biochemical Weapons Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Non-lethal Biochemical Weapons Sales Estimates and Forecasts (2021-2032)
- 1.3 Non-lethal Biochemical Weapons Market by Type
- 1.3.1 Directed Energy
- 1.3.2 Direct Contact
- 1.4 Global Non-lethal Biochemical Weapons Market Size by Type
- 1.4.1 Global Non-lethal Biochemical Weapons Market Size Overview by Type (2021-2032)
- 1.4.2 Global Non-lethal Biochemical Weapons Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Non-lethal Biochemical Weapons Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Non-lethal Biochemical Weapons Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Non-lethal Biochemical Weapons Industry Trends
- 2.2 Non-lethal Biochemical Weapons Industry Drivers
- 2.3 Non-lethal Biochemical Weapons Industry Opportunities and Challenges
- 2.4 Non-lethal Biochemical Weapons Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Non-lethal Biochemical Weapons Revenue (2021-2026)
- 3.2 Global Top Players by Non-lethal Biochemical Weapons Sales (2021-2026)
- 3.3 Global Top Players by Non-lethal Biochemical Weapons Price (2021-2026)
- 3.4 Global Non-lethal Biochemical Weapons Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Non-lethal Biochemical Weapons Major Company Production Sites & Headquarters
- 3.6 Global Non-lethal Biochemical Weapons Company, Product Type & Application
- 3.7 Global Non-lethal Biochemical Weapons Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Non-lethal Biochemical Weapons Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Non-lethal Biochemical Weapons Players Market Share by Revenue in 2025
- 3.8.3 2025 Non-lethal Biochemical Weapons Tier 1, Tier 2, and Tier 3
4 Non-lethal Biochemical Weapons Regional Status and Outlook
- 4.1 Global Non-lethal Biochemical Weapons Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Non-lethal Biochemical Weapons Historic Market Size by Region
- 4.2.1 Global Non-lethal Biochemical Weapons Sales in Volume by Region (2021-2026)
- 4.2.2 Global Non-lethal Biochemical Weapons Sales in Value by Region (2021-2026)
- 4.2.3 Global Non-lethal Biochemical Weapons Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Non-lethal Biochemical Weapons Forecasted Market Size by Region
- 4.3.1 Global Non-lethal Biochemical Weapons Sales in Volume by Region (2027-2032)
- 4.3.2 Global Non-lethal Biochemical Weapons Sales in Value by Region (2027-2032)
- 4.3.3 Global Non-lethal Biochemical Weapons Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-lethal Biochemical Weapons by Application
- 5.1 Non-lethal Biochemical Weapons Market by Application
- 5.1.1 Military Forces
- 5.1.2 Law Enforcement Agencies
- 5.2 Global Non-lethal Biochemical Weapons Market Size by Application
- 5.2.1 Global Non-lethal Biochemical Weapons Market Size Overview by Application (2021-2032)
- 5.2.2 Global Non-lethal Biochemical Weapons Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Non-lethal Biochemical Weapons Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Non-lethal Biochemical Weapons Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Lamperd Less Lethal
- 6.1.1 Lamperd Less Lethal Company Information
- 6.1.2 Lamperd Less Lethal Business Overview
- 6.1.3 Lamperd Less Lethal Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Lamperd Less Lethal Non-lethal Biochemical Weapons Product Portfolio
- 6.1.5 Lamperd Less Lethal Recent Developments
- 6.2 BAE Systems, Inc.
- 6.2.1 BAE Systems, Inc. Company Information
- 6.2.2 BAE Systems, Inc. Business Overview
- 6.2.3 BAE Systems, Inc. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 BAE Systems, Inc. Non-lethal Biochemical Weapons Product Portfolio
- 6.2.5 BAE Systems, Inc. Recent Developments
- 6.3 QinetiqGroup, Inc.
- 6.3.1 QinetiqGroup, Inc. Company Information
- 6.3.2 QinetiqGroup, Inc. Business Overview
- 6.3.3 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Product Portfolio
- 6.3.5 QinetiqGroup, Inc. Recent Developments
- 6.4 General Dynamics Corporation
- 6.4.1 General Dynamics Corporation Company Information
- 6.4.2 General Dynamics Corporation Business Overview
- 6.4.3 General Dynamics Corporation Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 General Dynamics Corporation Non-lethal Biochemical Weapons Product Portfolio
- 6.4.5 General Dynamics Corporation Recent Developments
- 6.5 TASER International,Inc.
- 6.5.1 TASER International,Inc. Company Information
- 6.5.2 TASER International,Inc. Business Overview
- 6.5.3 TASER International,Inc. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 TASER International,Inc. Non-lethal Biochemical Weapons Product Portfolio
- 6.5.5 TASER International,Inc. Recent Developments
- 6.6 Moog, Inc.
- 6.6.1 Moog, Inc. Company Information
- 6.6.2 Moog, Inc. Business Overview
- 6.6.3 Moog, Inc. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Moog, Inc. Non-lethal Biochemical Weapons Product Portfolio
- 6.6.5 Moog, Inc. Recent Developments
- 6.7 Raytheon Company
- 6.7.1 Raytheon Company Company Information
- 6.7.2 Raytheon Company Business Overview
- 6.7.3 Raytheon Company Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Raytheon Company Non-lethal Biochemical Weapons Product Portfolio
- 6.7.5 Raytheon Company Recent Developments
- 6.8 Chemring Group PLC.
- 6.8.1 Chemring Group PLC. Company Information
- 6.8.2 Chemring Group PLC. Business Overview
- 6.8.3 Chemring Group PLC. Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Chemring Group PLC. Non-lethal Biochemical Weapons Product Portfolio
- 6.8.5 Chemring Group PLC. Recent Developments
- 6.9 Textron Systems, Corp
- 6.9.1 Textron Systems, Corp Company Information
- 6.9.2 Textron Systems, Corp Business Overview
- 6.9.3 Textron Systems, Corp Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Textron Systems, Corp Non-lethal Biochemical Weapons Product Portfolio
- 6.9.5 Textron Systems, Corp Recent Developments
- 6.10 LRAD Corporation
- 6.10.1 LRAD Corporation Company Information
- 6.10.2 LRAD Corporation Business Overview
- 6.10.3 LRAD Corporation Non-lethal Biochemical Weapons Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 LRAD Corporation Non-lethal Biochemical Weapons Product Portfolio
- 6.10.5 LRAD Corporation Recent Developments
7 North America by Country
- 7.1 North America Non-lethal Biochemical Weapons Sales by Country
- 7.1.1 North America Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Non-lethal Biochemical Weapons Sales by Country (2021-2026)
- 7.1.3 North America Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
- 7.2 North America Non-lethal Biochemical Weapons Market Size by Country
- 7.2.1 North America Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
- 7.2.3 North America Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Non-lethal Biochemical Weapons Sales by Country
- 8.1.1 Europe Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Non-lethal Biochemical Weapons Sales by Country (2021-2026)
- 8.1.3 Europe Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
- 8.2 Europe Non-lethal Biochemical Weapons Market Size by Country
- 8.2.1 Europe Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
- 8.2.3 Europe Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Non-lethal Biochemical Weapons Sales by Country
- 9.1.1 Asia-Pacific Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Non-lethal Biochemical Weapons Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Non-lethal Biochemical Weapons Market Size by Country
- 9.2.1 Asia-Pacific Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Non-lethal Biochemical Weapons Sales by Country
- 10.1.1 South America Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Non-lethal Biochemical Weapons Sales by Country (2021-2026)
- 10.1.3 South America Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
- 10.2 South America Non-lethal Biochemical Weapons Market Size by Country
- 10.2.1 South America Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
- 10.2.3 South America Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Non-lethal Biochemical Weapons Sales by Country
- 11.1.1 Middle East and Africa Non-lethal Biochemical Weapons Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Non-lethal Biochemical Weapons Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Non-lethal Biochemical Weapons Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Non-lethal Biochemical Weapons Market Size by Country
- 11.2.1 Middle East and Africa Non-lethal Biochemical Weapons Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Non-lethal Biochemical Weapons Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Non-lethal Biochemical Weapons Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Non-lethal Biochemical Weapons Value Chain Analysis
- 12.1.1 Non-lethal Biochemical Weapons Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Non-lethal Biochemical Weapons Production Mode & Process
- 12.2 Non-lethal Biochemical Weapons Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Non-lethal Biochemical Weapons Distributors
- 12.2.3 Non-lethal Biochemical Weapons Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst